11 May 2020
Dolomite and Mologic collaborate to scale-up manufacture of nanoparticles for COVID-19 diagnostic tests
As the COVID-19 pandemic progresses in countries around the globe, there is an urgent need for rapid and reliable point-of-need detection testing. Dolomite Microfluidics and Mologic are working together to accelerate the development and launch of these tests. UK-based company Mologic is a leading developer of rapid response diagnostic tests for diseases such as malaria and Ebola virus disease....
